<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01564160</url>
  </required_header>
  <id_info>
    <org_study_id>11.0202</org_study_id>
    <secondary_id>176412</secondary_id>
    <secondary_id>12-02-003</secondary_id>
    <nct_id>NCT01564160</nct_id>
  </id_info>
  <brief_title>Assessment of PCSO-524 Relative to a Comparator Product</brief_title>
  <official_title>Assessment of the Acute and Chronic Bioavailability of Marine Lipid Fraction PCSO-524 Relative to a Comparator Product.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nutrasource Pharmaceutical and Nutraceutical Services, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pharmalink International Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nutrasource Pharmaceutical and Nutraceutical Services, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A marine lipid oil extract isolated from the New Zealand Greenshell® Mussel, Perna&#xD;
      canaliculus (P. canaliculus), contains a unique synergistic blend of marine fatty acids.&#xD;
&#xD;
      The objective of the this study is to evaluate the acute (5-hour) and chronic (21-day)&#xD;
      bioavailability of a fixed dose of PCSO-524 compared to a fish oil product in a population of&#xD;
      healthy adult participants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum Phospholipid</measure>
    <time_frame>Day 0 and Day 21</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Serum Lipid</measure>
    <time_frame>Day 21 @ 0 hours, 2 hours, 3 hours, 4 hours and 5 hours post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Free Fatty Acid</measure>
    <time_frame>Day 21 @ 0 hours, 2 hours, 3 hours, 4 hours and 5 hours post-dose</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Arm 1: PCSO-524</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PCSO-524</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2: Fish Oil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fish Oil</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fish Oil</intervention_name>
    <description>Source of omega-3 fatty acids.</description>
    <arm_group_label>Arm 2: Fish Oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>PCSO-524</intervention_name>
    <description>Extract of Greenshell Mussel</description>
    <arm_group_label>Arm 1: PCSO-524</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The individual is fluent in English and understands the study requirements&#xD;
&#xD;
          -  The participant is willing and able to comply with all requirements defined within&#xD;
             this protocol.&#xD;
&#xD;
          -  The individual is willing to provide written informed consent&#xD;
&#xD;
          -  The individual is male or female&#xD;
&#xD;
          -  The individual is between 18 and 65 years of age&#xD;
&#xD;
          -  The individual's blood EPA+DPA+DHA ≤ 5.2% at screening&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The individual is unable to or refuses to provide written informed consent&#xD;
&#xD;
          -  The individual has taken omega-3 supplements within 3 months of screening.&#xD;
&#xD;
          -  Supplements containing any of the following sources of omega-3s will exclude the&#xD;
             individual from the study: fish oil, flax oil, krill oil, green-lipped mussel, chia,&#xD;
             perilla, algea&#xD;
&#xD;
          -  The individual's blood EPA+DPA+DHA ≥ 5.2% at screening&#xD;
&#xD;
          -  The individual is female and pregnant or breastfeeding, or plans to be during the&#xD;
             trial period&#xD;
&#xD;
          -  The individual has known allergies product ingredients (fish/seafood)&#xD;
&#xD;
          -  The individual has any significant medical illness or condition&#xD;
&#xD;
          -  The individual has reported a history of drug dependence or substance abuse (excluding&#xD;
             nicotine)&#xD;
&#xD;
          -  The individual is taking lipid-altering medications (statins, niacin, carnitine,&#xD;
             fibrates etc.)&#xD;
&#xD;
          -  The individual is unable to abstain from caffeine, alcohol or physical activity for 24&#xD;
             hours before each treatment visit&#xD;
&#xD;
          -  The individual will be excluded if he or she has any additional conditions that, in&#xD;
             the Investigator's opinion, would preclude the participant from completing the study&#xD;
             or would not be in the best interest of the subject. This would include any&#xD;
             significant illness or unstable medical condition that could lead to difficulty&#xD;
             complying with the protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maggie D Laidlaw, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nutrasource Diagnostics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nutrasource Diagnostics Inc</name>
      <address>
        <city>Guelph</city>
        <state>Ontario</state>
        <zip>N1G0B4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://nutrasource.clinicalconductor.com/CCEWEB/Forms/frmUserHome.aspx?Mode=1</url>
    <description>Web Recruitment</description>
  </link>
  <verification_date>November 2012</verification_date>
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2012</study_first_posted>
  <last_update_submitted>November 30, 2012</last_update_submitted>
  <last_update_submitted_qc>November 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fish Oil</keyword>
  <keyword>EPA</keyword>
  <keyword>DHA</keyword>
  <keyword>Omega-Score</keyword>
  <keyword>Omega-3 Fatty Acids</keyword>
  <keyword>Green-Lipped Mussel</keyword>
  <keyword>Omega-score &lt; 5.2%</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

